AKR1C20, a member of the aldo-keto reductase (AKR) superfamily, found by mouse genomic analysis, exhibits the highest sequence identity (89%) with mouse liver 17b b-hydroxysteroid dehydrogenase (HSD) type 5, but its function remains unknown. In this report, we have expressed the recombinant AKR1C20 from its cDNA, and examined its properties. The purified enzyme was a 36-kDa monomer, and showed both 17b b-HSD and 3a a-HSD activities in the presence of NADP(H) as the coenzymes. While the K m values for testosterone and 5a a-dihydrotestosterone were high (Ͼ0.2 mM), those for 3a a-hydroxy-and 3-keto-steroids were low (0.3-5 m mM), resulting in high catalytic efficiency for the substrates. Although no significant dehydrogenase activity towards nonsteroidal alcohols was observed, the enzyme highly reduced a a-dicarbonyl compounds such as 16-ketoestrone, 9,10-phenanthrenequinone, acenaphthenequinone, 1-phenylisatin and camphorquinone. The pH optima of the dehydrogenase and reductase activities were 10.5 and 6.5-7.5, respectively. The enzyme was inhibited by sulfobromophthalein, hexestrol, indomethacin and flufenamic acid. The properties of AKR1C20 are distinct from those of previously known mouse 17b b-HSD type 5 (AKR1C6), 3a a-HSD (AKR1C14) and other members of the AKR1C subfamily. Thus, AKR1C20 is a novel 3a a(17b b)-HSD, which may also function as a reductase for xenobiotic a a-dicarbonyl compounds.
Hydroxysteroid dehydrogenases (HSDs) interconvert active and inactive steroid hormones and neurosteroids in target tissues, and are also involved in the metabolism of bile acids. [1] [2] [3] Mammalian HSDs belong to two protein superfamilies, the aldo-keto reductases (AKRs) 4) and short-chain dehydrogenases/reductases (SDRs). 5) While HSDs belonging to the SDR superfamily (most 17b-HSD isoenzymes, microsomal 3a-HSD, 3b-HSD and 11b-HSD) show low amino acid sequence identity. Those belonging to the AKR superfamily (17b-HSD type 5, cytosolic 3a-HSD and 20a-HSD) share more than 60% sequence identity, and are classified into an AKR1C subfamily. For example, human 20a-HSD, 17b-HSD type 5 and two isoenzymes of 3a-HSD are named AKR1C1, AKR1C3, AKR1C2 and AKR1C4, respectively. The genes for human AKR1C enzymes are clustered on chromosome 10p15. 1) The genomic clustering of the four human HSDs suggests that these genes arose from ancient duplication events followed by divergence. This is supported by a finding that eight members of the AKR1C subfamily exist in a cluster on mouse chromosome 13. 6) Seven of the eight mouse AKR1C members have been reported to be 17b-HSD type 5 (AKR1C6), 7) aldo-keto reductases (AKR1C12, 8) AKR1C13 8) and AKR1C19 9) ), 3a-HSD (AKR1C14), 10) 20a-HSD (AKR1C18) 11, 12) and 3(17)a-HSD (AKR1C21) 13) by the characterization of these recombinant enzymes. Currently, the function of AKR1C20 remains unknown. AKR1C20 exhibits the highest sequence identity (89%) with AKR1C6, which is identical to cytosolic 17b-HSD of mouse liver. [14] [15] [16] However, 17b-HSD exists in three multiple forms in mouse liver. 15, 16) To determine the functional relationship of AKR1C20 with the multiple forms of mouse liver 17b-HSD type 5, we examined the enzymatic properties of the recombinant AKR1C20.
MATERIALS AND METHODS

Chemicals
Prostaglandins were obtained from Cayman Chemicals (Ann Arbor, MI, U.S.A.), steroids were from Sigma Chemicals and Steraloids (Newport, RI, U.S.A.), and resins for column chromatography were from Amersham Biosciences (Piscataway, NJ, U.S.A.). 6-tert-Butyl-2,3-epoxy-5-cyclohexene-1,4-dione (TBE) and trans-benzene dihydrodiol were synthesized by the methods of Tajima et al. 17) and Platt and Oesch.
18) a-and b-3-Hydroxyhexobarbitals (3HBs) were gifts from Dr. R. Takenoshita (University of Fukuoka, Japan). All other chemicals were of the highest grade that could be obtained commercially.
cDNA Isolation The cDNA for AKR1C20 was amplified by reverse transcription (RT)-PCR from the total RNA of an 8-week-old male ICR mouse liver. The preparation of the total RNA and RT were carried out as described previously. 19 ) PCR was performed with Pfu DNA polymerase (Stratagene). The sense primer (5Ј-ATGAATTCC-AAGCAGCAGA) and antisense primer (5Ј-CATGA-CAGGGACCTCCAT) correspond to positions 1-18 and 954-973, respectively, of the sequence of a transcript of the Akr1c20 gene (Accession no. NM_054080). The PCR products of 973 base pairs were ligated into pCR T7/CT-TOPO vectors (Invitrogen), and the expression constructs were transfected into Escherichia coli BL21 (DE3) pLysS according to the protocol described by the manufacturer. The inserts of the cloned cDNAs were sequenced using a CEQ2000XL DNA sequencer (Beckman Coulter) to confirm that the deduced amino acid sequences of the cDNAs are identical to that of the transcript of the Akr1c20 gene.
Expression and Purification of Recombinant Proteins
The E. coli cells were cultured in a LB medium containing ampicillin (50 mg/ml) at 37°C until the absorbance at 600 nm reached 0.5, then isopropyl 1-thio-b-D-galactopyranoside (1 mM) was added, and the culture was continued for 24 h at 20°C. The cells were collected and the extract was prepared as described previously. 19) The recombinant AKR1C20 was purified at 4°C by (NH 4 ) 2 SO 4 fractionation and subsequent three column chromatography steps. The enzyme fraction, precipitated between 35 and 75% (NH 4 ) 2 SO 4 saturation, was dialyzed against Buffer A (10 mM Tris-HCl, pH 7.5, 5 mM 2-mercaptoethanol, 1 mM EDTA and 20% glycerol), and was applied to a Sephadex G-100 column (3ϫ70 cm) equilibrated with Buffer A. The enzyme fraction was applied to a QSepharose column (2ϫ20 cm) equilibrated with Buffer A. The enzyme was then eluted with a linear gradient of 0-0.1 M NaCl, dialyzed against Buffer A, and applied to a RedSepharose column (1.5ϫ5 cm) equilibrated with the same buffer. The column was washed with Buffer A and the enzyme was eluted with Buffer A containing 0.5 mM NADP ϩ and 0.1 M NaCl.
Assay of Enzyme Activity Dehydrogenase and reductase activities of AKR1C20 were assayed by measuring the rate of change in NAD(P)H fluorescence (at 455 nm with an excitation wavelength of 340 nm) and its absorbance (at 340 nm), respectively. The standard reaction mixture for the dehydrogenase activity consisted of 0.1 M potassium phosphate buffer, pH 7.4, 0.25 mM NADP ϩ , substrate and enzyme, in a total volume of 2.0 ml. To detect low activities in the cell extract and enzyme preparations during the purification, 0.1 M glycine-NaOH buffer, pH 9.5, was employed instead of the phosphate buffer. Testosterone (0.1 mM) was used as the substrate, unless otherwise noted. The reductase activity was determined in the phosphate buffer, pH 7.4, containing 0.1 mM NADPH and an appropriate amount of carbonyl substrate. One unit (U) of enzyme activity was defined as the amount that catalyzes the formation or oxidation of 1 mmol NADPH per minute at 25°C. The apparent K m and k cat values were determined over a range of five substrate concentrations at a saturating concentration of coenzyme by fitting the initial velocities to the Michaelis-Menten equation. The kinetic constants and IC 50 (inhibitor concentrations required for 50% inhibition) values are expressed as the means of two determinations. Protein concentration was determined by the method of Bradford 20) using bovine serum albumin as the standard.
Product Identification To identify the reaction products, ketosteroid reduction was conducted in a 2.0 ml system containing 0.1 mM NADPH, substrate (10 mM), enzyme (10 mg), and 0.1 M potassium phosphate, pH 7.4. The substrate and products were extracted into 6 ml ethyl acetate 1 h after the reaction was started at 37°C, and the resulting extract was evaporated to dryness. The reaction products in the reduction of ketosteroids were identified by liquid chromatography/mass spectrometry (LC/MS) as described previously. 13) RESULTS AND DISCUSSION Purification of Recombinant AKR1C20 SDS-PAGE analysis of the E. coli cell extracts (Fig. 1) shows that the cells transfected with the expression plasmids harboring the AKR1C20 cDNA overexpresses a 36-kDa protein, which was not present in the control cells transfected with the vector alone (Fig. 1) . The cell extract exhibited low NADP ϩ -linked dehydrogenase activity (0.001 U/mg) towards testosterone, but not towards alicyclic alcohols such as indan-1-ol and trans-benzene dihydrodiol, which are substrates for mouse 3-, 17a-, 20b-and 3(17)a-HSDs 10, [12] [13] [14] [15] in the AKR1C subfamily. The recombinant AKR1C20 was purified by assaying the testosterone dehydrogenase activity. The enzyme was eluted at a low molecular weight of approximately 35 kDa on the Sephadex G-100 chromatography step, suggesting its monomeric nature. The final preparation with the activity of 0.058 U/mg was greater than 99% pure (Fig. 1) , and the purification yield was 20% (9 mg/l of cells).
Properties of AKR1C20 The maximal rate of the NADP ϩ -linked testosterone dehydrogenase activity of the purified AKR1C20 was observed at pH 10.5. In the reverse reaction with NADPH as the coenzyme, the enzyme reduced S-camphorquinone, showing a broad pH optimum from 6.5 to 7.5. Therefore, the enzymatic properties of AKR1C20 were examined at a physiological pH of 7.4. AKR1C20 oxidized testosterone and dihydrotestosterones, but the K m values were high (Table 1) . Among other hydroxysteroids tested as the substrates for the enzyme, various 3a-hydroxysteroids were oxidized with low K m values, so that the catalytic efficiency (k cat /K m ) for the 3a-hydroxysteroids was higher (Ͼ10 folds) than that for the 17b-hydroxysteroids. The enzyme did not oxidize 17b-estradiol, 17a-hydroxysteroids (17a-estradiol, 4-androsten-17a-ol-3-one and 5b-androstan-17a-ol-3-one), 3b-hydroxysteroids (5b-androstan-3a-ol-17-one and 5b-pregnan-3b-ol-20-one) and 20a-hydroxysteroids (4-pregenen-20a-ol-3-one and 5b-pregnan-20a-ol-3-one). In addition, the enzyme did not show significant activity towards non-steroidal alcohols such as Sand R-forms of indan-1-ol and 1,2,3,4-tetrahydronaphth-1-ol, cylohex-2-en-1-ol, and trans-and cis-benzene dihydrodiols, which are oxidized by human and mouse 17b-HSDs 540
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Fig. 1. SDS-PAGE of E. coli Cell Extracts and Purified Recombinant AKR1C20
The gel (12.5%) was stained with 0.2% Coomassie Brilliant Blue. Lanes: a, the extract (10 mg) of E. coli cells transfected with the expression vector alone; b, the extract (10 mg) of E. coli cells transfected with the expression vector harboring AKR1C20 cDNA; c, the purified recombinant AKR1C20 (2 mg); and d, molecular mass markers (their positions are indicated in kDa).
(AKR1C3 21) and AKR1C6 7, 14, 16) ), human 3a-HSDs (AKR1C2 and AKR1C4) 22, 23) and mouse 3(17)a-HSD (AKR1C21). 13) Furthermore, AKR1C20 was inactive towards 9a,11b-prostaglandin F 2 , a good substrate of AKR1C3, 21 ) and 3-hydroxyhexobarbital, a substrate of mouse AKR1C19. 9) In the reverse reaction, AKR1C20 reduced various 3-ketosteroids with low K m values (Table 2) , and exhibited low activities towards 50 mM 5a-and 5b-androstan-3a-ol-17-ones (3 and 4 mU/mg, respectively). The steroid specificity is consistent with that in the forward reaction. The reduced products of 5a-and 5b-dihydrotestosterones by the enzyme were identified with 5a-and 5b-androstane-3a,17b-diols, respectively, by LC/MS. Even in the reduction of 5a-and 5b-androstane-3,17-diones by the enzyme only their 3a-hydroxy derivatives were formed. In contrast, only testosterone was detected as the product in the reduction of 4-androstene-3,17-dione. This suggests that 4-androstene-3,17-dione binds to the active site of the enzyme from its D-ring side, in contrast to the binding of the dihydroandrostanes from their Aring side. Although the enzyme did not oxidize estrone, 16-ketoestrone is the best substrate for the enzyme, exhibiting the highest k cat /K m value. As this steroid has a a-dicarbonyl structure, the enzyme also highly reduced other non-steroidal a-dicarbonyl compounds with aromatic ring(s) or alicyclic rings, but did not show significant activity towards aliphatic a-dicarbonyl compounds (2,3-hexaonedione, diacetyl and methylglyoxal). The enzyme reduced TBE and some aromatic aldehydes at low rates, and was inactive towards aliphatic aldehydes and ketones (1-propanal, 1-nonenal, 2-pentanone and acetone), and other aromatic ketones (4-nitroacetophenone, 4-benzoylpyridine and menadione).
The recombinant AKR1C20 was apparently NADP(H)-dependent. The K m and k cat /K m values for NADP ϩ determined in the presence of 10 mM 4-androsten-3a-ol-17-one as the substrate were 15 mM and 20 min Ϫ1 mM
Ϫ1
, respectively, and the respective values for NAD ϩ were 1.5 mM and 0.2 min
. In the reverse reaction with 0.5 mM S-camphorquinone as the substrate, the activity was detected in the presence of NADPH (K m =11 mM), but not in the presence of 0.1 mM NADH.
The dehydrogenase activity of AKR1C20 towards 10 mM 4-androsten-3a-ol-17-one was inhibited by sulfobromophthalein, hexestrol, dienestrol, stilbestrol, indomethacin, and flufenamic acid and the corresponding IC 50 values were 1.0, 2.7, 6.5, 8.0, 8.7 and 21 mM, respectively. Similarly, these compounds inhibited the testosterone dehydrogenase and Scamphorquinone reductase activities of the enzyme, supporting the broad substrate specificity of AKR1C20 for 3a-and 17b-hydroxysteroids and a-dicarbonyl compounds.
Comparison with Mammalian 3a a-and 17b b-HSDs Similar to the mRNA for 17b-HSD type 5 (AKR1C6), 7) the mRNA for AKR1C20 is highly expressed in mouse liver. 6) The steroid specificity of AKR1C20 in both the forward and reverse reactions is clearly distinct from those of the three multiple forms of mouse liver 17b-HSD, which exhibits high dehydrogenase activity for 17b-hydroxysteroids including 17b-estradiol and low 20a-HSD activity, but not 3a-HSD activity. 7, 14, 15) AKR1C20 also differs from the multiple forms of mouse liver 17b-HSD with respect to the substrate specificity for non-steroidal compounds: While AKR1C20 reduces only a-dicarbonyl compounds with aromatic or alicyclic ring(s), mouse liver 17b-HSD accepts both nonsteroidal alcohols and various carbonyl compounds as the substrates. 14, 16) The difference in the properties between AKR1C20 and mouse liver 17b-HSD, together with previous characterization of other mouse enzymes that belong to the AKR1C subfamily, [8] [9] [10] [11] [12] [13] supports the idea that the three multiple forms of mouse liver 17b-HSD are post-translational products from a gene for AKR1C6. 7) With respect to the dual steroid specificity, AKR1C20 can be classified as a 3a(17b)-HSD (EC 1.1.1.239), of which hamster liver 3a(17b)-HSD has been characterized. 24) AKR1C20 oxidized all the steroid substrates of hamster liver 3a(17b)-HSD, but differs from the hamster enzyme in its coenzyme specificity and K m values for 17b-hydroxysteroids. ϩ in mammalian liver cytosol, together with the high catalytic efficiency for 3-ketosteroids, suggests that AKR1C20 acts as 3-ketosteroid reductase. In mouse liver, regio-and stereo-specific 3a-HSD (AKR1C14) that differs from AKR1C20 with dual 3a(17a)-HSD activity is present, and exhibits higher k cat values for 3-keto and 3a-hydroxy-steroids than does AKR1C20. 10, 25) In addition, AKR1C14 is ubiquitously distributed in many mouse tissues in contrast to the liver-specific expression of AKR1C20. 6) Thus, the contribution of AKR1C20 to the steroid metabolism may be less than that of AKR1C14. On the other hand, AKR1C20 efficiently reduces non-steroidal a-dicarbonyl compounds with aromatic or alicyclic ring(s). This ability suggests that AKR1C20 functions in the conversion of reactive and lipid-soluble a-dicarbonyl compounds into less reactive and/or more soluble alcohols that may be excreted by further conjugation reaction.
The substrate specificity of AKR1C20 for 3a-hydroxy and 3-ketosteroids is unexpected, because its sequence identity (70%) with AKR1C14 is lower than that with AKR1C6 (89%). Penning 26) has pointed out ten residues (positions 24, 54, 55, 117, 118, 129, 226, 227, 306 and 310) in the substrate-binding pockets of HSDs (total amino acids of 322 or 323) in the AKR1C subfamily. Only four (Trp86, His117, Phe118 and Trp227) of the ten substrate-binding residues are the same between AKR1C20 and AKR1C14, whereas in addition to the four conserved residues Ile306 is conserved in AKR1C20 and AKR1C6. The above residues, excluding the four that are conserved, may be important for the steroid selectivity of the enzymes. Further site-directed mutagenesis studies targeting the residues that are not conserved in AKR1C20 and AKR1C14 or AKR1C6 will clarify their roles in steroid recognition.
